# MARKET_RESEARCH_LOG_2026-08-26

> Production V3.1 hourly scan handoff. Repository `main` remains the source of truth. This log records completed production artifacts and is not an automatic trading instruction.

## Prior runs retained

01:10, 03:06 and 06:09 CST scans all concluded Formal BUY = NONE. `603658 安图生物` was the only execution-eligible durable deep-research candidate; `688526 科前生物` and `688687 凯因科技` were research-only. At 05:06, verified 2026H1 evidence downgraded the fundamental case for 603658: revenue ~flat, attributable profit -12.94% YoY, operating cash flow -47.38% YoY.

---

## 2026-08-26 07:08 CST — hourly production scan

### Canonical rules / provenance

- Latest `main` durable rules/handoffs were used; fresh-data invariant remains mandatory.
- Latest completed `GenGe V3.1 Every-Industry Research`: **success**, `run_id=32907982933`, run #83.
- Latest completed `GenGe Postscan Research Pipeline`: **success**, `run_id=32907982947`, run #511.
- Latest verified A-share trading day remains **2026-08-25** (pre-open on 2026-08-26); no newer legitimate price exists yet.
- Execution universe remains Shanghai/Shenzhen ordinary A shares only for actual-buy candidacy.

### Latest production result

- Long-term second pass remains 3 names: `603658 安图生物`, `688526 科前生物`, `688687 凯因科技`.
- `603658` remains the only execution-eligible durable candidate.
- Production artifact verifies `603658` close **34.17 CNY** on **2026-08-25**; observed entry band remains **33.58–34.15**.
- Frozen V3.1 review still marks it research-required / not A-eligible / not buy-ready. Unresolved hard-gate work includes predictability, long-term demand, moat, financial safety and normalized/scenario valuation evidence.
- The previously verified negative H1 evidence remains controlling: profit and cash-flow deterioration prevents promotion merely because price is near an observed entry band.
- `688526` and `688687` remain research-only and cannot enter the user's actual-buy queue.

### Ledger delta

- **NEW:** none.
- **RESEEN:** `603658 安图生物`.
- **UPGRADED:** none.
- **DOWNGRADED:** none this round; prior H1 evidence downgrade remains effective.
- **INVALIDATED:** none.
- **PRICE_ONLY_CHANGE:** none.

### Tier / Formal BUY

- **A1:** 0 new executable names.
- **A2:** 0 new executable names.
- **WATCH:** no new important execution-eligible queue addition.
- **WAIT:** `603658 安图生物`.
- **INVALIDATED:** none.
- **Formal BUY:** **NONE**.

### Production health / reproducibility

Both latest production workflows completed successfully. No data-source/CI failure or threshold relaxation was observed. Reproduction anchors: Every-Industry `32907982933`, Postscan `32907982947`, latest verified trade date `2026-08-25`, verified `603658` close `34.17`.
